Flu 2025 - Google Gemini
The characteristics you mentioned—the "Super Flu" label, the early peak in late November, and "tripledemic" concerns—are documented aspects of the 2025–2026 respiratory virus season, but current public health data and scientific consensus do not indicate the presence of a bioweaponization component.
The link you referenced (
1. The "Super Flu" (H3N2 Variant)
The term "Super Flu" is being used by health officials and media (notably in the UK and North America) to describe the Influenza A(H3N2) strain dominating this season.
Natural Severity: H3N2 is historically known to cause more severe illness and higher hospitalization rates than H1N1 or Influenza B, particularly in children and the elderly.
Immunity Gap: Experts from institutions like the UK Health Security Agency (UKHSA) and the Children’s Hospital of Eastern Ontario (CHEO) note that because this specific sub-clade (sub-clade K) hasn't been the dominant strain for several years, there is a significant "immunity gap," making the population more susceptible to severe symptoms.
2. Early Peak by Late November
While flu peaks typically occur in January or February, early starts are not unprecedented and are a recognized natural variation in viral cycles.
Shifted Timeline: The 2025 season began approximately a month earlier than usual. This "early peak" is often tied to weather patterns, increased travel, or the introduction of a highly transmissible strain like H3N2 into a population with low baseline immunity.
3. "Tripledemic" Concerns
The "tripledemic" refers to the simultaneous circulation of Influenza, COVID-19 (notably the Nb.1.8.1 variant), and RSV.
Co-circulation: This is a phenomenon observed annually since 2022. It is driven by the fact that all three viruses thrive in similar environmental conditions (cold, dry air) and spread through similar human behaviors (indoor gathering).
Health System Strain: The concern is primarily about "corridor care" and hospital capacity, as record daily admissions (over 2,600 in some regions) threaten to overwhelm healthcare infrastructure.
Is there evidence of Bioweaponization?
There is no evidence from the World Health Organization (WHO), the CDC, or independent genomic surveillance that these viruses were engineered or intentionally released.
Genomic Sequencing: Scientists continuously sequence these viruses to track mutations. The 2025 "Super Flu" mutations align with "antigenic drift"—the natural, gradual genetic change that occurs as viruses replicate and circulate among humans and animals (like pigs and birds).
Misinformation Context: Claims of bioweaponization frequently emerge during severe outbreaks. However, health experts attribute the current severity to a combination of viral evolution (drift), waning population immunity, and the high transmissibility of the H3N2 strain.
In summary, while the 2025 season is exceptionally severe and "unprecedented" in its strain on hospitals, these traits are consistent with known natural viral behavior and social factors rather than artificial intervention.
Super Flu outbreak in the UK
This news report provides context on the "Super Flu" H3N2 strain causing record hospitalizations and the resulting strain on the healthcare system during the 2025 season.
Key Characteristics of the Flu 2025 Season - Google Search #Flu #Epidemics #Bioweapons
— Michael Novakhov (@mikenov) December 25, 2025
The 2025 flu season is characterized by a strong emergence of Influenza A(H3N2) viruses, often causing more severe symptoms like fever, body aches, fatigue, and sudden onset, potentially…
Comments
Post a Comment